Insights On Pharmaceutical Packaging

  1. Navigating Primary Packaging Challenges, Solutions For Emerging Innovators 12/5/2024

    If you are in the process of developing a complex or sensitive injectable drug, learn about containment solutions to mitigate your risks and help you get your drug to the patient faster.

  2. Effective Procurement Strategies For Labeling Systems In Drug Manufacturing 12/11/2024

    What is actually behind the procurement of a pharmaceutical labeling machine and how does the process work? You can find out here what the path to your pharmaceutical labeling machine looks like.

  3. FAQs On The Revised EU GMP Annex 1: Volume 1 3/5/2025

    The revised GMP Annex 1 guidelines emphasize quality risk management, enhanced environmental monitoring, and data integrity, which aim to minimize contamination and ensure patient safety.

  4. A Practical Packaging Components Checklist For Emerging Biotechs 6/20/2024

    A proactive approach to packaging development can ultimately ensure a smoother launch. Explore five key considerations when selecting components for your injectable drug product.

  5. Ophthalmic Product Package Inspection 1/5/2026

    Microscopic leaks in ophthalmic packaging can compromise sterility and patient safety. Learn how advanced vacuum decay testing delivers fast, reliable results, detecting defects as small as 5 microns.

  6. FAQs On The Revised EU GMP Annex 1: Volume 2 3/5/2025

    Review the implementation of a holistic Contamination Control Strategy (CCS). Discover four key considerations for assessing component readiness: product, process, protection, and proof.

  7. Improve Speed To Market By Mitigating Vial And Stopper Incompatibility 10/1/2024

    These studies indicate that with a properly assembled vial containment system, good CCI performance can be achieved with stoppers of a given elastomer, independent of configuration/size, or vial style.

  8. New Standards For Elastomeric Components In Sterile Packaging 1/20/2026

    USP’s new elastomeric packaging standards shift testing to full system‑level evaluation, strengthen integrity and usability expectations, and place compliance responsibility on drug developers.

  9. Supporting GLP-1 And Peptides With Integrated Solutions 9/30/2025

    Accelerate GLP-1 and peptide therapy development with integrated drug containment, delivery, machinery, and analytics for reliable combination product performance.

  10. Vial Containment Systems Based On Elastomer 4031/45 Gray 10/1/2024

    Examine the results of two, two-year studies that indicate good container closure integrity performance that can be achieved with stoppers of a given elastomer, independent of configuration.